Mini-Organism-on-a-Chip May Replace Test Animals in Drug Studies
By LabMedica International staff writers Posted on 16 Feb 2015 |
Image: Using the compact multi-organ chip (comparable in size to a one-euro piece), and those of three separate microcircuits, researchers can study the regeneration of certain kidney cells (Photo courtesy of Fraunhofer Institute for Material and Beam Technology IWS).
A team of German biomedical researchers has developed a highly miniaturized micro-circulatory system for testing the response of various body organs to drugs or other chemicals.
Investigators at the Fraunhofer Institute for Material and Beam Technology IWS (Dresden, Germany) and colleagues at the Institute for Biotechnology at the Technical University of Berlin (Germany) have been working at the cutting edge of research dedicated to replacing test animals with relevant, reproducible alternatives.
To this end they developed a "mini-organism-on-a-chip." This system was designed to mimic the physiology of a human being on a scale of 1:100,000. The chip carries a series of micro-compartments that can be loaded with cells from different organs and are connected by a micro-channel circulatory system. A miniature pump is capable of manipulating flow rates of less than 0.5 microliters per second through the channels. This system ensures there is a constant flow of liquid cell culture medium throughout the mini-organism. The exact configuration of the chip—the number of mini-organs and the connection to the micro-channels—can be changed to accommodate different sets of questions and different applications.
“Most medications work systemically— that is to say, on the organism as a whole. In doing so, toxic substances frequently emerge through metabolic processes, which in turn damage only certain organs,” said Dr. Frank Sonntag, project leader at the Fraunhofer Institute for Material and Beam Technology. “We know today that certain kidney cells, the endothelial cells, play a key role in almost every kidney disease. With the in vitro tests to date, there was always the problem that the endothelial cells worked only under current. Here, our multi-organ chip could offer a test environment that would allow you to observe how cells regenerate following an injury."
Related Links:
Fraunhofer Institute for Material and Beam Technology IWS
Institute for Biotechnology at the Technical University of Berlin
Investigators at the Fraunhofer Institute for Material and Beam Technology IWS (Dresden, Germany) and colleagues at the Institute for Biotechnology at the Technical University of Berlin (Germany) have been working at the cutting edge of research dedicated to replacing test animals with relevant, reproducible alternatives.
To this end they developed a "mini-organism-on-a-chip." This system was designed to mimic the physiology of a human being on a scale of 1:100,000. The chip carries a series of micro-compartments that can be loaded with cells from different organs and are connected by a micro-channel circulatory system. A miniature pump is capable of manipulating flow rates of less than 0.5 microliters per second through the channels. This system ensures there is a constant flow of liquid cell culture medium throughout the mini-organism. The exact configuration of the chip—the number of mini-organs and the connection to the micro-channels—can be changed to accommodate different sets of questions and different applications.
“Most medications work systemically— that is to say, on the organism as a whole. In doing so, toxic substances frequently emerge through metabolic processes, which in turn damage only certain organs,” said Dr. Frank Sonntag, project leader at the Fraunhofer Institute for Material and Beam Technology. “We know today that certain kidney cells, the endothelial cells, play a key role in almost every kidney disease. With the in vitro tests to date, there was always the problem that the endothelial cells worked only under current. Here, our multi-organ chip could offer a test environment that would allow you to observe how cells regenerate following an injury."
Related Links:
Fraunhofer Institute for Material and Beam Technology IWS
Institute for Biotechnology at the Technical University of Berlin
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples